SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042532
Filing Date
2019-11-12
Accepted
2019-11-12 07:14:33
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aveo-10q_20190930.htm 10-Q 3079616
2 EX-31.1 aveo-ex311_10.htm EX-31.1 16543
3 EX-31.2 aveo-ex312_7.htm EX-31.2 16548
4 EX-32.1 aveo-ex321_6.htm EX-32.1 4483
5 EX-32.2 aveo-ex322_9.htm EX-32.2 4494
  Complete submission text file 0001564590-19-042532.txt   11826685

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aveo-20190930.xml EX-101.INS 2869016
7 XBRL TAXONOMY EXTENSION SCHEMA aveo-20190930.xsd EX-101.SCH 72433
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aveo-20190930_cal.xml EX-101.CAL 45170
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aveo-20190930_def.xml EX-101.DEF 289752
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20190930_lab.xml EX-101.LAB 560476
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20190930_pre.xml EX-101.PRE 438363
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617- 531-2130
AVEO PHARMACEUTICALS INC (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34655 | Film No.: 191206049
SIC: 2834 Pharmaceutical Preparations